HIV Clinical Trials
Volume 17, 2016 - Issue 1
Open access
1,058
Views
2
CrossRef citations to date
0
Altmetric
Original Articles
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study
Eugénio TeófiloDepartment of Internal Medicine, Hospital Dos Capuchos, Lisboa, PortugalCorrespondence[email protected]
, Nuno Rocha-PereiraCentro Hospitalar de São João, Porto, Portugal
, Birger KuhlmannGemeinschaftspraxis Dres. Kuhlmann/Holm/Heiken, Hannover, Germany
, Antonio AntelaInfectious Diseases Unit, Hospital Clínico Universitario, Santiago de Compostela, Spain
, Heribert KnechtenHIV Schwerpunktpraxis Dr. Heribert Knechten, Aachen, Germany
, Jesús SantosInfectious Diseases Unit, Hospital Virgen de la Victoria, Malaga, Spain
, Maria Jesús Jiménez-ExpósitoBristol-Myers Squibb, Rueil-Malmaison, France
& on behalf of the REMAIN study group show all
Pages 17-28
|
Published online: 05 Feb 2016
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.